Complement-mediated T-cell depletion of bone marrow: comparison of T10B9.1A-31 and Muromonab-Orthoclone OKT3

References

• Champlin R. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation. Hematol Oncol Clin North Am 1990;4:687–98.
   PubMed Web of Science ®Google Scholar
• Marmont AM, Horowitz MM, Gale RP et al. T-cell deple-tion of HLA-identical transplants in leukemia. Blood 1991;78:2120–30.
   PubMed Web of Science ®Google Scholar
• Champlin RE, Passweg JR, Zhang MJ et al. T-cell depletionof bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 2000;95:3996–4003.
   PubMed Web of Science ®Google Scholar
• Sullivan KM, Parkman R. The pathophysiology and treatment of graft-versus-host disease. Clin Haematol 1983; 12:772–89.
   Google Scholar
• Ferrara JLM, Deeg HJ. Graft-versus-host disease. N EnglMed 1991;324:669–74.
   Google Scholar
• Murphy W, Blazar B. New strategies for preventing graft-versus-host disease . Curr Opin Immunol 1999;11:509–15.
   PubMedGoogle Scholar
• Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 trans-plantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl 7 Med 1993;328:593–602.
   PubMed Web of Science ®Google Scholar
• Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparsion of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989;73: 1340–50.
   PubMed Web of Science ®Google Scholar
• Lamb LS, Gee AP, Henslee-Downey PJ et al. Phenotypic and functional reconstitution of peripheral blood lympho- cytes following T cell-depleted bone marrow transplanta-tion from partially mismatched related donors. Bone Marrow Transplant 1998;21:461–71.
   PubMedGoogle Scholar
• Greenberg P, Riddell S. Deficient cellular immunity-finding and fixing the defects. 1999;285:546–51.
   Google Scholar
• Shapiro RS, McClain K, Frizzera G et al. Epstein—Barr virus associated B-cell lymphoproliferative disorder following bone marrow transplantation. Blood 1988;71:1234.
   PubMed Web of Science ®Google Scholar
• Gerritsen EJ, Stam ED, Hermans J et al. Risk factors for developing EBV-related B cell lymphoproliferative disor-ders (BLPD) after non-HLA-identical BMT in children. Bone Marrow Transplant 1996;18:377–82.
   PubMed Web of Science ®Google Scholar
• Glucksburg M, Storb R, Fefer A et al. Clinical manifesta-tions of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295–304.
   Google Scholar
• Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients. Am 7 Med 1980; 69:204–17.
   Google Scholar
• Cook-Craig A, Owen A, Reeder G et al. Component pro-cessing and intraoperative autotransfusion during bone marrow harvest. Prog Clin Biol Res 1994;389:613–19.
   Google Scholar
• Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. 7 Hematother 1996;5:213–26.
   PubMedGoogle Scholar
• Kawanishi Y, Flomenberg N, Cook-Craig A et al. A new lim-iting dilution culture system for the detection of T cell subsets in T cell-depleted marrow grafts. 7 Hematother 1996;5:485–95.
   PubMedGoogle Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. .7 Am Stat Assoc 1958;53:457.
   Google Scholar
• Hester J, Rondon G, Huh Y et al. Principles of bone marrow processing and progenitor cell/mononuclear cell concen-trate collection in a continuous flow blood cell separation system. y Hematother 1995;4:299–306.
   Google Scholar
• Keever-Taylor C, Collins N, Carter S et al. Report on the standardization of clonogeneic hematopoietic precursor assays for the unrelated donor bone marrow transplantation trial. Blood. 1997;90:1639a
   Google Scholar
• Henslee-Downey PJ, Abhyankar SH, Parrish RS et al. Use of partially mismatched related donors extends access to allo-geneic marrow transplant. Blood 1997;89:3869–72.
   Google Scholar
• Keever-Taylor CA, Bredeson C, Loberiza F et al. Analysis of risk factors for the development of GvHD after T cell depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T cell depletion. Biol Blood Marrow Transplant. In press.
   Google Scholar
• O'Reilly RJ, Small TN, Papadopoulos E et al. Biology and adoptive cell therapy of Epstein—Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts. Immunol Rev 1997;157:195–216.
   Google Scholar
• Cooley MA, Farrelly H, O'Flaherty E et al. T cell depletion of bone marrow for clinical marrow allografting: optimal- ization of conditions for depletion by anti-C D2 and anti-CD8 monoclonal antibodies with rabbit complement, and for detection of residual T cell content. Pathology 1987; 19:131–6.
   Google Scholar
• Waid TH, Lucas BA, Amlot P et al. TIOB9.1 A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treat-ment of solid organ allograft rejection. 7 Kidney Dis 1989; 5: 61–70.
   Google Scholar
• Campana D, Thompson JS, Amlot P et al. The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage. y Immunol 1987;138:648–55.
   Google Scholar
• Lamb LS, Gee AP, Hazlett LJ et al. Influence of T cell depletion method on circulating T cell reconstitution and potential role in the graft-versus-leukemia effect. Cytotherapy 1999;1:7–19.
   PubMed Web of Science ®Google Scholar
• Mullersman JE, White G, Tung KS. Differential staining of human alpha beta and gamma delta T cells by the fluores-cein conjugate of an anti-CD3 monoclonal antibody. Clin Exp Immunol 1991;84: 329–8.
   Google Scholar
• Kawanishi Y, Passweg J, Drobyski WR et al. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. Bone Marrow Transplant 1997;19:1069–77.
   PubMed Web of Science ®Google Scholar
• Drobyski WR, Majewski D, Hanson G. Graft-facilitating doses of ex vivo activated gamma delta T cells do not cause lethal murine graft-vs.-host disease. Biol Blood Marrow Transplant 1999;5:222–30.
   Google Scholar
• Drobyski WR, Vodanovic-Jankovic S, Klein J. Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infu-sion therapy in mice. y Immuno12000;165:1639–40.
   Google Scholar
• Voogt PJ, Falkenburg JHF, Fibbe WE et al. Normal hematopoi-etic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/C D3-, T cell receptor 78+ /CD3 and T cell receptor-af3+ /CD3' lym-phocytes. .7 Immunol1989;142: 1774–80.
   Google Scholar
• Doherty PC. The function of 78 T cells . Br .7 Haematol 1992;81:321–4.
   PubMed Web of Science ®Google Scholar
• Lamb LS, Henslee-Downey PJ, Parrish RS et al. Increased frequency of TCR gamma delta' T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia. Hematother 1996;5:503–9.
   PubMedGoogle Scholar
• Henslee PJ, Thompson JS, Romond EH et al. T cell deple-tion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect. Transplant Proc 1987;19:2701–6.
   PubMed Web of Science ®Google Scholar
• Henslee-Downey PJ, Romond E, Harder E et al. Sucessful engraftment and control of graft versus host disease (GvHD) following three antigen mismatched haploidenti-cal marrow transplant. Blood 1991;78 (Suppl I):189a.
   Google Scholar
• Lee C, Brouillette M, Lamb L et al. Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplan-tation. P rog Clin Biol Res 1994;389:523–32.
   PubMedGoogle Scholar
• Keever-Taylor C, Bredison C, Klein J et al. Factors affecting engraftment following T cell depleted bone marrow trans-plantation: role of growth factor use and CD34+ cell dose. Bone Marrow Transplant 2001;27:791–800.
   PubMed Web of Science ®Google Scholar
• Brown SA, Lucas BA, Waid TH et al. T 10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action. Clin Transplant 1996;10:607–13.
   Google Scholar
• Norton J, al-Saffar N, Sloane JP. An immunohistological studyof gamma/delta lymphocytes in human cutaneous graft-versus-host disease. Bone Marrow Transplant 1991;7:205–8.
   Google Scholar
• Norton J, al-Saffar N, Sloane JP. Immunohistological study of distribution of 7/8 lymphocytes after allogeneic bone marrow transplantation. 7 Clin Pathol 1992;45: 1027–8.
   Google Scholar
• Tsuji S, Char D, Bucy RP, et al. Gamma delta T cells are sec-ondary participants in acute graft-versus-host reactions initiated by CD4' alpha beta T cells. Eur 7 Immunol 1996;26:420–7.
   PubMedGoogle Scholar